Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Vycor Medical (VYCO) Equity Average (2016 - 2025)

Vycor Medical has reported Equity Average over the past 15 years, most recently at -$4.1 million for Q4 2025.

  • Quarterly Equity Average fell 10.0% to -$4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.1 million through Dec 2025, down 10.0% year-over-year, with the annual reading at -$3.9 million for FY2025, 10.85% down from the prior year.
  • Equity Average was -$4.1 million for Q4 2025 at Vycor Medical, down from -$3.9 million in the prior quarter.
  • Over five years, Equity Average peaked at $67549.5 in Q4 2021 and troughed at -$4.1 million in Q4 2025.
  • The 5-year median for Equity Average is -$3.1 million (2023), against an average of -$2.9 million.
  • Year-over-year, Equity Average soared 103.47% in 2021 and then crashed 4363.82% in 2022.
  • A 5-year view of Equity Average shows it stood at $67549.5 in 2021, then crashed by 4363.82% to -$2.9 million in 2022, then decreased by 13.85% to -$3.3 million in 2023, then fell by 12.44% to -$3.7 million in 2024, then fell by 10.0% to -$4.1 million in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Equity Average are -$4.1 million (Q4 2025), -$3.9 million (Q3 2025), and -$3.9 million (Q2 2025).